Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Schwartz

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Cancer|February 4, 2010
Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1)Jonathan D Schwartz, Eric K Rowinsky, Hagop Youssoufian, et al.
World Neurosurgery|May 4, 2021
Precision Medicine in Pediatric Bithalamic Glioma: Significance of the EGFR exon 20 Insertion MutationAnshit Goyal, Cody L Nesvick, Aditya Raghunathan, et al.
Cancer|February 4, 2010
Rationale for the development of IMC-3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet-derived growth factor receptor alphaGaurav D Shah, Nick Loizos, Hagop Youssoufian, et al.
Human Gene Therapy|February 15, 2022
<i>Letter to the Editor:</i> Hematopoietic Stem and Progenitor Cell Mobilization and Collection for Patients Diagnosed with Osteopetrosis and Hurler SyndromeJulián Sevilla, June Iriondo, Elena Sebastian, et al.
Advanced Drug Delivery Reviews|April 23, 2022
Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors - An updateErica A Power, Julian S Rechberger, Sumit Gupta, et al.
The Oncologist|October 27, 2005
Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progressionJonathan D Schwartz, Max Sung, Myron Schwartz, et al.
Annals of Hematology|February 18, 2020
Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalizationEileen Nicoletti, Gayatri Rao, Juan A Bueren, et al.
Journal of Neurosurgery. Pediatrics|June 22, 2023
Predicting disease progression and the need for tumor-directed treatment in tectal plate gliomasMegan M J Bauman, Max B Giesken, Ryan M Naylor, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 8, 2023
Copeptin levels in hospitalized infants and children with suspected vasopressin-dependent disorders: a case seriesAlaa Al Nofal, Christian Hanna, Aida N Lteif, et al.
Current Drug Targets|July 23, 2011
Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancersEric K Rowinsky, Jonathan D Schwartz, Naseem Zojwalla, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Cancer|February 4, 2010
Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1)Jonathan D Schwartz, Eric K Rowinsky, Hagop Youssoufian, et al.
World Neurosurgery|May 4, 2021
Precision Medicine in Pediatric Bithalamic Glioma: Significance of the EGFR exon 20 Insertion MutationAnshit Goyal, Cody L Nesvick, Aditya Raghunathan, et al.
Cancer|February 4, 2010
Rationale for the development of IMC-3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet-derived growth factor receptor alphaGaurav D Shah, Nick Loizos, Hagop Youssoufian, et al.
Human Gene Therapy|February 15, 2022
<i>Letter to the Editor:</i> Hematopoietic Stem and Progenitor Cell Mobilization and Collection for Patients Diagnosed with Osteopetrosis and Hurler SyndromeJulián Sevilla, June Iriondo, Elena Sebastian, et al.
Advanced Drug Delivery Reviews|April 23, 2022
Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors - An updateErica A Power, Julian S Rechberger, Sumit Gupta, et al.
The Oncologist|October 27, 2005
Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progressionJonathan D Schwartz, Max Sung, Myron Schwartz, et al.
Annals of Hematology|February 18, 2020
Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalizationEileen Nicoletti, Gayatri Rao, Juan A Bueren, et al.
Journal of Neurosurgery. Pediatrics|June 22, 2023
Predicting disease progression and the need for tumor-directed treatment in tectal plate gliomasMegan M J Bauman, Max B Giesken, Ryan M Naylor, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 8, 2023
Copeptin levels in hospitalized infants and children with suspected vasopressin-dependent disorders: a case seriesAlaa Al Nofal, Christian Hanna, Aida N Lteif, et al.
Current Drug Targets|July 23, 2011
Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancersEric K Rowinsky, Jonathan D Schwartz, Naseem Zojwalla, et al.
Pageof 6